首页 | 本学科首页   官方微博 | 高级检索  
检索        

肾移植患者麦考酚酸的群体药动学研究
引用本文:焦正,张明,梁惠琪,郁韵秋,钟明康,陆伟跃.肾移植患者麦考酚酸的群体药动学研究[J].中国药学杂志,2007,42(1):57-61.
作者姓名:焦正  张明  梁惠琪  郁韵秋  钟明康  陆伟跃
作者单位:1. 复旦大学药学院,药剂教研室,上海,200032;复旦大学附属华山医院,临床药学研究室,上海,200040
2. 复旦大学附属华山医院,肾脏科,上海,200040
3. 复旦大学附属华山医院,临床药学研究室,上海,200040
4. 复旦大学药学院,药物分析教研室,上海,200032
5. 复旦大学药学院,药剂教研室,上海,200032
基金项目:上海市自然科学基金;上海市卫生局百人计划项目Ⅱ期课题
摘    要: 目的建立国人肾移植患者在移植初期3个月的群体药动学模型。方法研究对象为52例采用环孢素、吗替麦考酚酯(MMF)和糖皮质激素三联免疫抑制治疗方案的肾移植患者。收集其服药后不同时相的血样560份以及相应的生理、病理和实验室检查数据。运用非线性混合效应模型建立麦考酚酸的群体药动学模型,考察身高、体重、年龄、性别、剂量、血清肌酐、移植术后天数、合并用药、UGT1A9启动子11个单核苷酸基因多态性等对药动学参数的影响。模型验证采用200次bootstrap。结果以一级吸收和消除的二房室模型拟合麦考酚酸的药动学过程为佳,一级速率条件算法计算。体重和移植术后时间是麦考酚酸清除率的影响因素。麦考酚酸清除率的群体药动学公式为:CL/F(L·h-1)=0.554.TBW(kg).(1-e-1.14·POD)。MPA平均清除率为31 L·h-1,与白种人的文献报道值相吻合。Bootstrap法的验证结果与模型计算值也相符。结论建立的麦考酚酸群体药动学模型有一定代表性,为采用Bayesian法进行个体化给药奠定基础。

关 键 词:麦考酚酸  群体药动学  非线性混合效应模型
文章编号:1001-2494(2007)01-0057-05
收稿时间:2006-11-12;
修稿时间:2006-11-12

Population Pharmacokineties of Mycophenolic Acid in Chinese Adult Renal Transplant Patients
JIAO Zheng , ZHANG Ming, LIANG Hui-qi, YU Yun-qiu, ZHONG Ming-kang, LU Wei-yue.Population Pharmacokineties of Mycophenolic Acid in Chinese Adult Renal Transplant Patients[J].Chinese Pharmaceutical Journal,2007,42(1):57-61.
Authors:JIAO Zheng  ZHANG Ming  LIANG Hui-qi  YU Yun-qiu  ZHONG Ming-kang  LU Wei-yue
Institution:a. Department of Pharmaceutics ; b. Department of Drug Analysis,School of Pharmacy, Fudan University,Shanghai 200032, China; a. Department of Pharmacy; b. Department of Nephrology,Huashan Hospital, Fudan University,Shanghai 200040, China
Abstract:OBJECTIVE To characterize the population pharmacokinetics(PK) of mycophenolic acid(MPA) in Chinese adult renal transplant patients during the first three months after transplantation.METHODS Fifty-two Adult renal transplant recipients,who were orally administered with mycophenolate mofetil,cyclosporine and corticosteroids,were enrolled in this study.Totally 560 blood samples were collected from their MPA PK profiles with relating demographical,pathological and laboratory test results.Nonlinear mixed effect modeling was employed to establish the population PK model of MPA.Age,gender,height,weight,dose,serum creatinine,co-administraed drugs,post-operation day and 11 single nucleotide polymorphisms in UGT1A9 promoter area etc,were screened as covariates.The final PK model was validated using 200 bootstrap techniques.RESULTS A two-compartment model with first-order absorption and elimination provided the best fitting.First order conditional estimation was employed as the algorithm.Total body weight and time after transplantation were identified as covariates influencing the clearance of MPA.The final population PK model for MPA was listed below:CL/F(L·h-1)=0.554·TBW(kg)·(1-e-1.14·POD).The final population model yielded mean population CL/F value of 31 L·h-1,which was consistent with those of previous reports conducted in Caucasians.Bootstrapped results showed close agreement between pairs of bootstrapped and final model parameter estimates.CONCLUSION It is the first time that population PK parameters for MPA are determined in Chinese renal transplant recipients.These can be used to achieve specific target MPA concentrations or areas under the concentration-time curve with the Bayesian methods.
Keywords:mycophenolic acid  population pharmacokinetics  nonlinear mixed effect modeling
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国药学杂志》浏览原始摘要信息
点击此处可从《中国药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号